Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.

Numinus Wellness Inc.

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Mind Medicine (MindMed) Inc.

Valis Bioscience focuses on improving the measurement and treatment of psychiatric and neurological disorders. The company specializes in psychedelic trials and rare and orphan disorders, developing tools for clinical trials and digital therapeutics.

Valis Bioscience

Numinus is a California based company that manufactures products for the home theater and hospitality industries. Our product line includes StarDomes, StarTiles and LED lighting and controls. We are the innovator of ready-to-install fiber optic starfields. 

Stardomes™ are fiberglass ceiling domes with an airbrushed sky mural, twinkling fiber optic stars, and a cove light the creates a numinous sunrise and sunset. StarDomes are available in many sizes including custom. 

StarTiles™ are acoustic panels wrapped in Guilford fabric with twinkling fiber optic stars that can drop into a grid ceiling or mount right over drywall. They add acoustic value to a room while created a magical starry night.

Our LED line includes flexible strips and down light cans, as well as low voltage wall dimmers. Controllers are available for RGB color changing or for single color LED loads, and can communicate with home automation systems through serial port.

We are a consumer driven company aiming to provide the finest quality products with the highest level of customer service.

Numinus

Numinus has a new Domain!!

find us at www.numinus.net!!

keep an eye out for more exciting news from Numinus?

Metric
Company Name	Numinus Wellness Inc.	Mind Medicine (MindMed) Inc.	Valis Bioscience
Symbol	NUMI	MNMD
MSH ID	COM:NUMINUS	CO:MINDMED	COM:VALISBIOSCIENCE
Market	STOCKS	STOCKS	PRIVATE
Sector	Healthcare	Healthcare	Healthcare & Health Services
Industry	Medical - Care Facilities	Biotechnology	Clinical Research
Country	CA	CA	US
Stage		Post-IPO Equity
Employee Count	200	57
Website	numinus.com	mindmed.co	valisbioscience.com
LinkedIn	numinus		valisbioscience
Founders

Metric
Market Cap	9.07M	500.56M
Enterprise Value
Monthly Web Traffic		17.91K
Web Traffic Growth		-0.36
Valuation
Raised Capital		75M

Metric
Revenue	16.40M
Revenue (LTM)
Revenue (NTM)
Gross Profit	5.92M
EBITDA	-17.43M
Operating Income	-19.44M
Net Income	-21.40M
EPS	-0.08
Diluted EPS	-0.08
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.35
Operating Profit Margin	-0.93
EBITDA Margin	-1.06
Net Profit Margin	-1.17
Return on Equity	-1.49
Return on Assets	-1.40
Return on Capital Employed	-1.54

COM:NUMINUS

Numinus Wellness Inc.

Last Close

0.05

22/11 20:15

Market Cap

12.82M

Beta: -

Volume Today

349.40K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-1.07
P/B Ratio	3.00
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.04
EV Multiple	-0.27

Metric
Days Sales Outstanding	35.49
Days Payables Outstanding	59.40
Days Inventory Outstanding	4.17
Operating Cycle	39.66
Cash Conversion Cycle	-13.85
Asset Turnover	1.53

Metric
Operating Cash Flow	-16.10M
Free Cash Flow	-16.37M
Cash Flow to Debt	-2.80
Operating Cash Flow/Sales	-0.68
Free Cash Flow Yield	-0.62

Metric
Cash & Equivalents	6.07M
Accounts Receivable	-937.23K
Inventory
Goodwill
Debt to Capitalization	0.40
Debt to Assets	0.35
Current Ratio	2.10
Quick Ratio	2.09

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.09
R&D to Revenue	0.03
SG&A to Revenue	1.23